Decision Diagnostics Corp. (DECN)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 1.97 Million USD | -16.82% |
| 2019 | 2.37 Million USD | 6.41% |
| 2018 | 2.23 Million USD | 18.91% |
| 2017 | 1.88 Million USD | 159.19% |
| 2016 | 725.48 Thousand USD | 148.43% |
| 2015 | 292.03 Thousand USD | 0.0% |
| 2012 | 6.19 Million USD | -48.83% |
| 2011 | 12.11 Million USD | -35.96% |
| 2010 | 18.91 Million USD | -3.54% |
| 2009 | 19.6 Million USD | 31.12% |
| 2008 | 14.95 Million USD | 139.09% |
| 2007 | 6.25 Million USD | -67.46% |
| 2006 | 19.22 Million USD | 242.34% |
| 2005 | 5.61 Million USD | 2982.89% |
| 2004 | 182.11 Thousand USD | 140.21% |
| 2003 | 75.81 Thousand USD | 3690.65% |
| 2002 | 2000.00 USD | -99.79% |
| 2001 | 940.62 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q2 | 552.38 Thousand USD | 2.71% |
| 2021 Q3 | 518.51 Thousand USD | -6.13% |
| 2021 Q1 | 537.79 Thousand USD | 3.07% |
| 2020 FY | 1.97 Million USD | -16.82% |
| 2020 Q1 | 573.79 Thousand USD | -21.71% |
| 2020 Q2 | 362.86 Thousand USD | -36.76% |
| 2020 Q3 | 520.69 Thousand USD | 43.5% |
| 2020 Q4 | 521.8 Thousand USD | 0.21% |
| 2019 Q4 | 732.86 Thousand USD | 38.68% |
| 2019 Q3 | 528.45 Thousand USD | -5.04% |
| 2019 FY | 2.37 Million USD | 6.41% |
| 2019 Q2 | 556.51 Thousand USD | -0.87% |
| 2019 Q1 | 561.39 Thousand USD | -5.38% |
| 2018 Q1 | 559 Thousand USD | -20.06% |
| 2018 Q4 | 593.32 Thousand USD | -9.16% |
| 2018 FY | 2.23 Million USD | 18.91% |
| 2018 Q2 | 430.48 Thousand USD | -22.99% |
| 2018 Q3 | 653.17 Thousand USD | 51.73% |
| 2017 Q2 | 422.74 Thousand USD | 19.06% |
| 2017 Q1 | 355.06 Thousand USD | -3.35% |
| 2017 FY | 1.88 Million USD | 159.19% |
| 2017 Q4 | 699.31 Thousand USD | 73.41% |
| 2017 Q3 | 403.27 Thousand USD | -4.6% |
| 2016 Q3 | 309.08 Thousand USD | 22.39% |
| 2016 FY | 725.48 Thousand USD | 148.43% |
| 2016 Q4 | 367.35 Thousand USD | 18.85% |
| 2016 Q2 | 252.54 Thousand USD | 54.13% |
| 2016 Q1 | 163.84 Thousand USD | -26.51% |
| 2015 Q2 | 89.65 Thousand USD | 0.61% |
| 2015 Q4 | 222.96 Thousand USD | 99.46% |
| 2015 Q3 | 111.78 Thousand USD | 24.68% |
| 2015 Q1 | 89.1 Thousand USD | 0.0% |
| 2015 FY | 292.03 Thousand USD | 0.0% |
| 2014 Q2 | 136.94 Thousand USD | -37.89% |
| 2014 Q1 | 220.5 Thousand USD | 0.0% |
| 2013 Q3 | 304.97 Thousand USD | -19.22% |
| 2013 Q2 | 377.52 Thousand USD | -66.03% |
| 2013 Q1 | 1.11 Million USD | 649.88% |
| 2012 Q4 | 148.22 Thousand USD | -87.88% |
| 2012 Q2 | 2.32 Million USD | -7.44% |
| 2012 Q3 | 1.22 Million USD | -47.28% |
| 2012 Q1 | 2.5 Million USD | 66.25% |
| 2012 FY | 6.19 Million USD | -48.83% |
| 2011 Q4 | 1.5 Million USD | -57.95% |
| 2011 Q2 | 3.89 Million USD | 24.77% |
| 2011 Q1 | 3.12 Million USD | -34.68% |
| 2011 FY | 12.11 Million USD | -35.96% |
| 2011 Q3 | 3.58 Million USD | -7.99% |
| 2010 Q2 | 5.25 Million USD | 27.25% |
| 2010 Q3 | 4.75 Million USD | -9.55% |
| 2010 FY | 18.91 Million USD | -3.54% |
| 2010 Q4 | 4.78 Million USD | 0.62% |
| 2010 Q1 | 4.12 Million USD | -16.38% |
| 2009 Q2 | 5.1 Million USD | 0.93% |
| 2009 Q3 | 4.49 Million USD | -12.03% |
| 2009 Q4 | 4.93 Million USD | 9.92% |
| 2009 FY | 19.6 Million USD | 31.12% |
| 2009 Q1 | 5.05 Million USD | -11.19% |
| 2008 Q2 | 3.02 Million USD | 7.98% |
| 2008 Q4 | 5.69 Million USD | 65.62% |
| 2008 Q3 | 3.43 Million USD | 13.86% |
| 2008 Q1 | 2.79 Million USD | 9.76% |
| 2008 FY | 14.95 Million USD | 139.09% |
| 2007 Q4 | 2.54 Million USD | 60.74% |
| 2007 Q3 | 1.58 Million USD | 52.92% |
| 2007 Q2 | 1.03 Million USD | -4.29% |
| 2007 Q1 | 1.08 Million USD | 89.82% |
| 2007 FY | 6.25 Million USD | -67.46% |
| 2006 Q2 | 9 Million USD | 20.65% |
| 2006 Q3 | 2.17 Million USD | -75.87% |
| 2006 Q4 | 570.69 Thousand USD | -73.74% |
| 2006 FY | 19.22 Million USD | 242.34% |
| 2006 Q1 | 7.46 Million USD | 419.67% |
| 2005 Q1 | 2.09 Million USD | 209002.59% |
| 2005 Q2 | 1.07 Million USD | -48.99% |
| 2005 Q4 | 1.43 Million USD | 42.66% |
| 2005 Q3 | 1 Million USD | -5.94% |
| 2005 FY | 5.61 Million USD | 2982.89% |
| 2004 FY | 182.11 Thousand USD | 140.21% |
| 2004 Q3 | 51.67 Thousand USD | -10.22% |
| 2004 Q2 | 57.55 Thousand USD | 3.9% |
| 2004 Q1 | 55.39 Thousand USD | 8.37% |
| 2004 Q4 | 1004.00 USD | -98.06% |
| 2003 Q3 | 22.84 Thousand USD | 1592.44% |
| 2003 Q1 | 500.00 USD | 12.36% |
| 2003 Q2 | 1350.00 USD | 170.0% |
| 2003 FY | 75.81 Thousand USD | 3690.65% |
| 2003 Q4 | 51.11 Thousand USD | 123.72% |
| 2002 Q2 | 674.00 USD | -99.62% |
| 2002 Q4 | 445.00 USD | -11.0% |
| 2002 Q3 | 500.00 USD | -25.82% |
| 2002 FY | 2000.00 USD | -99.79% |
| 2002 Q1 | 175.65 Thousand USD | 0.0% |
| 2001 FY | 940.62 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | NaN% |
| Allstar Health Brands, Inc. | - USD | NaN% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 195.23 Million USD | 100.0% |
| Café Serendipity Holdings, Inc. | 44.55 Thousand USD | 100.0% |
| Health Advance Inc. | - USD | NaN% |
| HealthWarehouse.com, Inc. | 20.28 Million USD | 100.0% |
| LIGAND PHARMACEUTICAL INC | 131.31 Million USD | 100.0% |
| MedGen, Inc. | 1.05 USD | 100.0% |
| Omni Health, Inc. | 4.69 Million USD | 100.0% |
| Oxford Investments Holdings Inc. | 61.16 Thousand USD | 100.0% |
| Pineapple, Inc. | 381.89 Thousand USD | 100.0% |
| ScripsAmerica, Inc. | 30.85 Million USD | 100.0% |